Evidence map›Paper›PMID 35354858›Full record

ArticleScientific reports2022

An original approach to measure ligand/receptor binding affinity in non-purified samples.

Estelle Rascol, Anouk Dufourquet, Rim Baccouch, Pierre Soule, Isabel D Alves

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Mechanistic insights into ligand selectivity inActa pharmaceutica Sinica. B · 2026
    Article
  4. Article
  5. Article
  6. The antimicrobial activity of ETD151 defensin is dictated by the presence of glycosphingolipids in the targeted organisms.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Estelle RascolUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, 33600, Pessac, France. estelle.rascol@u-bordeaux.fr.
Anouk DufourquetUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, 33600, Pessac, France.
Rim BaccouchUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, 33600, Pessac, France.
Pierre SouleApplication Team, NanoTemper Technologies GmbH, Munich, Germany.
Isabel D AlvesUniv. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, 33600, Pessac, France.
Centre National de la Recherche Scientifique · FRInstitut Européen de Chimie et Biologie · FRInstitut Polytechnique de Bordeaux · FRNanoTemper Technologies (Germany) · DEUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several biochemical and biophysical methods are available to determine ligand binding affinities between a biological target and its ligands, most of which require purification, labelling or surface immobilisation. These measurements, however, remain challenging in regards to membrane proteins, as purification processes require their extraction from their native lipid environment, which may in turn impact receptor conformation and functionality. In this study, we have developed a novel experimental procedure using microscale thermophoresis (MST) directly from cell membrane fragments, to determine different ligand binding affinities to a membrane protein, the dopamine D2 receptor (D2R). In order to achieve this, two main challenges had to be overcome: determining the concentration of dopamine D2R in the crude sample; finding ways to minimize or account for non-specific binding of the ligand to cell fragments. Using MST, we were able to determine the D2R concentration in cell membrane fragments to approximately 36.8 ± 2.6 pmol/mg. Next, the doses-responses curves allowed for the determination of K

Indexed as

Membrane ProteinsLigandsMolecular ConformationProtein BindingLigandsMembrane Proteins

Identifiers

PMID35354858
PMCPMC8967833
OpenAlexW4226110043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.